Estradiol/ dydrogesterone (Femoston, Femoston conti)

BNF:
Endocrine
Status:
Green
Decision Date:
March 2020
 

Comments

See menopause management guideline

Femoston- 2nd line sequential (cyclical) combined tablets. Used in perimenopause and during the first year or two after menopause.

Femoston Conti- 2nd line continuous combined tablets for post-menopausal women.

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app